Molecular Tumor Diagnostics for Precision Medicine

53rd HEIDELBERG
GRAND ROUNDS
Molecular Tumor Diagnostics for
Precision Medicine: SWOT Analysis 2020
Chairs:
Prof. Dr. Peter Schirmacher
Prof. Dr. Christof von Kalle
Please register by 18th July
at the latest.
For this event, two points for
continuing education will be given
by the Landesärztekammer.
Within the practical year, the points
will be recognized in the field of
internal medicine and surgery.
July 19th, 2016
16.00 – 18.00
Lecture Hall, Institute of Pathology
THOLOGIE
A
P
E
R
H
A
150 J
RG
HEIDELBE
Information and registration:
Fortbildungs- und Veranstaltungs
organisation des Nationalen Centrums
für Tumorerkrankungen
Heidelberg School of Oncology
Im Neuenheimer Feld 460
69120 Heidelberg
Phone +49 (0)6221 566558
Fax +49 (0)6221 565094
[email protected]
www.nct-heidelberg.de/anmeldung
Wilko Weichert, MD, is the Director of
the Institute of Pathology of the Technical
University in Munich. He is also member
of the board of the German Society of
Pathology. Dr. Weichert is pathologist
by training and a dedicated molecular
pathologist with a specific focus on molecular
biomarker translation into clinical diagnostics.
With this research focus, he centrally
contributes molecular diagnostics expertise
to several large research consortia such as
the German Cancer Consortium. On the other
side of the spectrum, he is also involved
into regulatory and health insurance issues
in the implementation of novel diagnostic
algorithms into real world patient care.
Marketing sponsored by:
Amgen GmbH AstraZeneca GmbH
Boehringer Ingelheim Pharma GmbH & Co. KG
Bristol-Myers Squibb GmbH & Co. KGaA
Dako Deutschland GmbH Merck Serono GmbH
MSD Sharp Dohme GmbH Novartis Pharma GmbH
Pfizer Pharma GmbH
Roche Pharma AG
750,00 €
500,00 €
1500,00 €
750,00 €
500,00 €
1000,00 €
1000,00 €
1000,00 €
300,00 €
750,00 €
Diaceutics Group
Jeroen Krijgsveld is a professor of
Proteomics at Heidelberg University and
heads the Division 'Proteomics of stem cells
and cancer' at DKFZ. He did post-doctoral
work at Harvard Medical School, was an
assistant professor at Utrecht University,
and a Team Leader at EMBL from 2008-2015.
His research focuses on the development
of quantitative proteomic methodologies
to study the expression, interaction and
secretion of proteins at a global scale. In
particular, his interest is to investigate how
the proteome is dynamically regulated
in time and space, and to understand
processes that are fundamental to cancer
biology and to pluripotency in stem cells.
Klaus Pantel is Chairman of the Institute of
Tumour Biology at the University Medical
Center Hamburg-Eppendorf and Member
of the Executive Board of Directors of the
University Cancer Center Hamburg (UCCH).
The pioneer work of Prof. Pantel in the
field of cancer micrometastasis, circulating
tumor cells and circulating nucleic acids
(ctDNA, microRNAs) is reflected by > 400
publications (incl. NEJM, Lancet, Nature
Journals, Cancer Cell, Science Translational
Medicine, Cancer Discovery, PNAS, JCO,
JNCI, Cancer Res.) and has been awarded
the AACR Outstanding Investigator Award
for Breast Cancer Research 2010, German
Cancer Award 2010, and ERC Advanced
Investigator Grant 2011.
Prof. Dr. Peter SchirmacherIntroduction: SWOT
Director of the Institute of Pathology at the University
Hospital Heidelberg
Prof. Dr. Wilko WeichertHow much is enough? – Real world genetic tissue based
Director of the Institute of Pathology at the
predictive molecular testing in oncology
University Munich
Prof. Dr. Klaus Pantel
Liquid Biopsies: Technical challenges and clinical implications
Director Dept. of Tumorbiology, University Medical
Center, Hamburg-Eppendorf
Prof. Dr. Jeroen Krijgsveld
Proteomics in the age of next-generation sequencing
German Cancer Reseach Center, Heidelberg
Prof. Dr. Christof von Kalle
Discussion Forum
Director of National Center for Tumor Diseases (NCT)
Heidelberg
51st HEIDELBERG GRAND ROUNDS on 1st March 2016, 16:00 – 18:00
I will participate.
Name
First name
Person/s will accompany me:
Fortbildungs- und Veranstaltungsorganisation des Nationalen Centrums
für Tumorerkrankungen (NCT)
Heidelberg School of Oncology
Im Neuenheimer Feld 460
Name / First name
69120 Heidelberg
Location/street
Signature
Registration via fax: 06221 565094 or www.nct-heidelberg.de/anmeldung

Download Report